Latanoprostene Bunod Ophthalmic Solution, 0.024%

Gland Pharma Limited🇺🇸 United States

FDA Page

Effective Date: May 2, 2025
Approval ID: 1beedfbd-5e2b-4ab1-ab8e-8320e69af1ea
Products: 2 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION. LATANOPROSTENE BUNOD ophthalmic solution. Initial U.S. Approval: 2017

Quick Stats

Total Products2

Labelers2

Label Sections14

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.